Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00307_DB01017_nanopub.RAzV4B8Yde3gi3iBYyrfrDb69mdPV5o5Y1jN8xsDVINRI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00307_DB01017 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00307_DB01017 label "DDI between Bexarotene and Minocycline - Tetracycline derivatives like minocycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. Due to the risk of developing pseudotumor cerebri (also known as intracranial hypertension), avoid this combination of drugs if possible. If used concomitantly, monitor for evidence of this interaction (eg, dizziness, diplopia, headache). [drugbank_resource:DB00307_DB01017]" assertion.
- drugbank_resource:DB00307_DB01017 identifier "drugbank_resource:DB00307_DB01017" assertion.
- drugbank_resource:DB00307_DB01017 title "DDI between Bexarotene and Minocycline - Tetracycline derivatives like minocycline may enhance the adverse/toxic effect of Retinoic Acid Derivatives. Due to the risk of developing pseudotumor cerebri (also known as intracranial hypertension), avoid this combination of drugs if possible. If used concomitantly, monitor for evidence of this interaction (eg, dizziness, diplopia, headache)." assertion.
- drugbank:DB00307 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00307_DB01017 assertion.
- drugbank:DB01017 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00307_DB01017 assertion.